Caprolactam Chemicals Limited (CAPRO.BO)
INR 51.5
(-2.33%)
INR 51.5
(-2.33%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 18.22 Million | 8.58 Million | 30.48 Million | 12.54 Million | 21.8 Million | 29.55 Million |
| Net Income | 2.72 Million | 29.7 Million | -14.74 Million | 8.91 Million | 12.57 Million | 5.01 Million |
| Depreciation & Amortization | 15.82 Million | 11.52 Million | 10.34 Million | 10.65 Million | 10.22 Million | 9.68 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -4.44 Million | -34.41 Million | 35.38 Million | -5.08 Million | -2.73 Million | 11.67 Million |
| Other non-cash items | 4.89 Million | 1.76 Million | -505 Thousand | -1.93 Million | 1.73 Million | 3.17 Million |
| Investing Cash Flow | -16.44 Million | -21.41 Million | -47.48 Million | -4.78 Million | -7.33 Million | -37.77 Million |
| Investments in PPE | -16.52 Million | -21.56 Million | -47.54 Million | -4.92 Million | -7.25 Million | -37.77 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 79.99 Thousand | 152 Thousand | 55 Thousand | 138.56 Thousand | -78.9 Thousand | - |
| Financing Cash Flow | -3.22 Million | 13.66 Million | 13.26 Million | -5.93 Million | -14.27 Million | 3.5 Million |
| Debt repayment | -1.75 Million | -19.34 Million | -16.03 Million | -2.97 Million | -8.29 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -3.22 Million | 13.66 Million | 13.26 Million | -2.96 Million | -5.98 Million | 3.5 Million |
| Accounts receivables | 392 Thousand | -6.43 Million | 4.37 Million | -1.7 Million | -2.6 Million | 7.3 Million |
| Accounts payables | - | 6.43 Million | -4.37 Million | 1.7 Million | 2.6 Million | - |
| Inventory | 206 Thousand | 347 Thousand | -148 Thousand | -251.68 Thousand | 98.4 Thousand | 2.1 Million |
| Other working capital | -3.67 Million | -34.75 Million | 35.53 Million | -4.83 Million | -2.83 Million | 2.26 Million |
| Cash at beginning of period | 2.3 Million | 1.47 Million | 5.2 Million | 3.38 Million | 3.19 Million | 7.91 Million |
| Cash at end of period | 865 Thousand | 2.3 Million | 1.47 Million | 5.2 Million | 3.38 Million | 3.19 Million |
| Capital Expenditure | -16.52 Million | -21.56 Million | -47.54 Million | -4.92 Million | -7.25 Million | -37.77 Million |
| Effect of forex changes on cash | - | - | - | 2.00 | - | - |
| Net cash flow / Change in cash | -1.44 Million | 836 Thousand | -3.73 Million | 1.82 Million | 189.2 Thousand | -4.72 Million |
| Free Cash Flow | 1.7 Million | -12.97 Million | -17.05 Million | 7.62 Million | 14.54 Million | -8.22 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.66 Million | 2.72 Million | 1.17 Million | -1.63 Million | -560 Thousand | 1.21 Million |
| Depreciation & Amortization | - | 15.82 Million | - | - | 3.81 Million | 3.81 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -4.44 Million | - | - | -4.9 Million | -4.9 Million |
| Other non-cash items | 2.66 Million | 4.89 Million | -1.17 Million | 1.63 Million | 4.31 Million | 2.54 Million |
| Investing Cash Flow | - | -16.44 Million | - | - | -2.18 Million | -2.18 Million |
| Investments in PPE | - | -16.52 Million | - | - | -2.18 Million | -2.18 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 79.99 Thousand | - | - | 9000.00 | 9000.00 |
| Financing Cash Flow | - | -3.22 Million | - | - | -1.25 Million | -1.25 Million |
| Debt repayment | - | -1.75 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -3.22 Million | - | - | -1.25 Million | -1.25 Million |
| Accounts receivables | - | 392 Thousand | - | - | -3.23 Million | -3.23 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | 206 Thousand | - | - | 95.5 Thousand | 95.5 Thousand |
| Other working capital | - | -3.67 Million | - | - | -1.76 Million | -1.76 Million |
| Cash at beginning of period | - | 2.3 Million | - | - | - | - |
| Cash at end of period | - | 865 Thousand | - | - | -762.5 Thousand | -762.5 Thousand |
| Capital Expenditure | - | -16.52 Million | - | - | -2.18 Million | -2.18 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | -1.44 Million | - | - | -762.5 Thousand | -762.5 Thousand |
| Free Cash Flow | - | 1.7 Million | - | - | 479.5 Thousand | 479.5 Thousand |
AXLX
BAHI3
603896
SPG
TBLLF
3618